Drugs Made In America Acquisition (DMIIR) Receivables - Other (2025)
Drugs Made In America Acquisition (DMIIR) posted quarterly Receivables - Other of $566269.0 for Q3 2025.
Powered by 
Analysis
Drugs Made In America Acquisition (DMIIR) Receivables - Other (2025) Analysis & Trends
Drugs Made In America Acquisition (DMIIR) has reported Receivables - Other for 1 consecutive years, with $566269.0 the latest figure, recorded in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Cluster Group Holdings | 8.00 Bn | 8.00 Bn | - |
| 2 | Agriculture & Natural Solutions Acquisition | 853.42 Mn | 853.17 Mn | - |
| 3 | K&F Growth Acquisition | 836.15 Mn | 836.15 Mn | - |
| 4 | Armada Acquisition | 666.54 Mn | 666.49 Mn | - |
| 5 | Pioneer Acquisition I | 652.74 Mn | 652.27 Mn | - |
| 6 | Oxley Bridge Acquisition | 652.11 Mn | 652.11 Mn | - |
| 7 | Titan Acquisition | 651.43 Mn | 941.85 Mn | - |
| 8 | GSR IV Acquisition | 622.22 Mn | 622.22 Mn | - |
| 9 | Launch One Acquisition | 618.70 Mn | 618.70 Mn | - |
| 10 | Drugs Made In America Acquisition | 5.10 Mn | 5.10 Mn | - |